WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
0.08
%
1,14%
Latest
7.1
High
7.1
Low
6.91
Volume
22 890
Turnover (SEK)
160 247
Value (MSEK)
152,4

Board

CEO

  • Peter Morsing

Chairman Of The Board

  • Ulf Björklund

Board

  • Gudrun Anstrén
  • Kjell Stenberg
  • Martin Olovsson
  • Peter Ström
  • Sten Trolle
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 12,02 12,02 2019-03-31
Nordnet Pensionsförsäkring 10,31 10,31 2019-03-31
Kjell Stenberg 5,97 5,97 2019-04-18
Tommy Andersson 4,24 4,24 2019-04-19
Lars-Erik Forsgårdh 2,34 2,34 2019-03-31
Nils Qvarner 1,16 1,16 2019-03-31
Leif Bertils 1,13 1,13 2019-03-31
Bostadsrättsbyggarna Svenska Holding AB 0,94 0,94 2019-03-31
Swedbank Försäkring 0,82 0,82 2019-03-31
Livförsäkringsbolaget Skandia 0,74 0,74 2019-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Inquiry Financial